Aktuellt
SENASTE
With four orders with a total value of 7.5 MSEK in the last eight months, of which two booked in the first two months of 2022, it is now clear that fucoxanthin offers the most significant commercial potential for Simris and that B2B is the most lucrative way forward. While this warrants an upward adjustment of our somewhat dated sales forecast (from 12 to 15 MSEK in 2022), Simris ability to leverage its unique algae platform will also depend on its access to growth capital.
LÄS MER
